2028년까지 유럽 식물 기반 백신 시장 예측 – 백신 유형(세균 백신, 바이러스 백신, 기생충 백신 및 기타), 출처(담배 식물, 옥수수, 감자 및 기타) 및 애플리케이션별 코로나19 영향 및 지역 분석( 인플루엔자, 지카 바이러스, 에볼라 바이러스, 가금류 질병 등)

시장 소개

유럽 식물 기반 백신 시장에는 독일, 프랑스, 영국 및 기타 유럽 지역. 유럽은 노인 인구 증가, 만성 바이러스 질환 유병률 증가, 지역 내 새로운 항원 개발에 대한 높은 수요 등의 요인으로 인해 예측 기간 중 두 번째로 큰 시장입니다. 또한, 연구 및 연구에 대한 자금 지원을 늘리고 있습니다. 개발 활동은 앞으로 이 지역에 더 많은 기회를 추가할 가능성이 높습니다.

신뢰할 수 있고 시의적절한 코로나19 테스트는 모니터링, 예방, 터치 녹음, 감염 통제 및 COVID-19의 임상 관리. 유럽 질병 예방 통제 센터(ECDC)는 이용 가능한 공중 보건 도구와 테스트 능력을 고려하여 인구 집단의 바이러스 전파 수준에 대한 구체적인 지침과 함께 EU를 위한 분석 테스트 전략을 제안했습니다. 2020년 9월 유럽연합 집행위원회 건강 보호 위원회가 실시한 조사에서는 신속 항원 검사 사용에 관한 회원국의 활동을 조사했습니다. 15개 EU 회원국이 설문조사에 응답했으며, 그 중 5개 주에서는 코로나19 팬데믹 대응의 특정 측면에 대해 신속한 항원 검사를 사용하고 있습니다. 15개 국가 중 9개 국가는 현재 임상/진단 효율성과 향후 신속 항원 검사의 사용을 평가하기 위해 임상 검증 시험 또는 시범사업을 진행하고 있으며, 2개 회원국에서는 신속 항원 검사 사용을 고려하지 않고 있습니다. 보고서에 따르면 일부 국가에서는 감염 조기 발견, 접촉자 추적 및/또는 신속한 격리, 확인된 사례 및 접촉자 격리를 위한 연구 정책의 일환으로 이 테스트를 사용합니다. 다른 국가에서는 RT-PCR 최적 표준을 사용할 수 없거나 시기적절하지 않은 외딴 지역에서 실험실 테스트를 보장하기 위해 신속 항원 테스트를 명시적으로 사용합니다.

시장 개요 및 역학

공장 유럽의 백신 기반 시장은 2021년 3억 640만 달러에서 2028년에는 7억 515만 달러로 성장할 것으로 예상됩니다. 2021년부터 2028년까지 CAGR 12.6%로 성장할 것으로 추정됩니다. 인플루엔자는 인플루엔자 바이러스에 의해 발생하는 전염성이 높은 호흡기 질환입니다. 인플루엔자 바이러스는 유전적으로 지속적으로 변화하고 있으며, 유도 면역 및 백신 제제에 큰 영향을 미칩니다. 세계보건기구(WHO)에 따르면, 감염된 개인이 기침이나 재채기를 할 때 바이러스가 포함된 비말(감염성 비말)이 공기 중으로 퍼지고 최대 1미터까지 이동할 수 있으며, 이 비말을 들이마시는 가까운 사람들을 감염시킬 수 있습니다. 임신부 여성, 소아과 의사, 노인과 의사, 만성 질환을 앓고 있는 면역력이 낮은 환자, 의료 종사자 모두 인플루엔자 감염 위험이 있습니다. 그 결과 유럽에서는 백신에 대한 수요가 급증했습니다. 이러한 요인들은 예측 기간 동안 전 세계 식물 기반 백신 시장을 발전시킬 가능성이 높습니다.

주요 시장 부문

유럽 식물 기반 백신 시장은 백신 유형, 공급원, 적용 분야 및 국가로 분류됩니다. 백신 유형에 따라 유럽 식물 기반 백신 시장은 박테리아 백신, 바이러스 백신, 기생충 백신, 식물 유래 바이러스 유사 입자 등으로 분류됩니다. 박테리아 백신 부문은 2021년 시장에서 가장 큰 점유율을 차지했습니다. 출처를 기준으로 유럽 식물 기반 백신 시장은 담배 식물, 옥수수, 감자 등으로 분류됩니다. 담배 식물 부문은 2021년 시장에서 가장 큰 점유율을 차지했습니다. 적용에 따라 유럽 식물 기반 백신 시장은 인플루엔자, 지카 바이러스, 에볼라 바이러스, 가금류 질병, 코로나19 등으로 분류됩니다. 인플루엔자 부문은 2021년 시장에서 가장 큰 점유율을 차지했습니다. 국가를 기준으로 유럽 식물 기반 백신 시장은 프랑스, 독일, 이탈리아, 스페인, 영국 및 기타 유럽으로 분류됩니다. 2021년에는 독일이 가장 큰 시장 점유율을 차지했습니다.

등재된 주요 출처 및 회사

유럽 식물 기반 백신 시장에 대한 이 보고서를 준비하는 데 참조된 몇 가지 주요 1차 및 2차 소스로는 회사 웹사이트, 연례 보고서, 재무 보고서, 국가 정부 문서, 통계 데이터베이스 등이 있습니다. 보고서에 나열된 주요 회사는 British American Tobacco plc입니다. Creative Biolabs, Inc.; 리프 익스프레션 시스템즈 리미티드(Leaf Expression Systems Ltd.); 레니오바이오; 루멘 바이오사이언스, 인코포레이티드; 및 ZYUS Life Sciences Inc.

보고서 구매 이유

유럽의 식물 기반 백신 시장 환경을 이해하고 가장 많이 사용되는 시장 부문을 식별합니다. 강력한 수익을 보장할 가능성이 높습니다.
유럽 식물 기반 백신 시장의 끊임없이 변화하는 경쟁 환경을 이해하여 경쟁에서 앞서 나가십시오.
가장 유망한 판매 가능성이 있는 시장 부문을 식별하여 유럽 식물 기반 백신 시장에서 M&A 및 파트너십 거래를 효율적으로 계획합니다.
지식을 갖추는 데 도움이 됩니다. 유럽 식물 기반 백신 시장의 다양한 부문의 시장 성과에 대한 통찰력 있고 포괄적인 분석을 통해 비즈니스 결정을 내립니다.
2021~2028년 유럽의 다양한 부문별 시장 수익 예측을 얻습니다. 지역.

유럽 식물 기반 백신 시장 세분화
유럽 식물 기반 백신 시장 - 백신 유형별

세균 백신
바이러스 백신
기생충 백신 span>
식물 유래 바이러스 유사 입자
기타

< span>유럽 식물 기반 백신 시장 - 기준 출처

담배나무
옥수수
감자
< span>기타

유럽 식물 기반 백신 시장 - 용도별

유럽 식물 기반 백신 시장 - 국가별

유럽 식물 기반 백신 시장 - 회사 프로필

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Europe Plant-based Vaccines Market – By Vaccine Type

1.3.2 Europe Plant-based Vaccines Market – By Source

1.3.3 Europe Plant-based Vaccines Market – By Application

1.3.4 Europe Plant-based Vaccines Market – By Country

2. Europe Plant-based Vaccines Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Europe Plant-based Vaccines Market– Market Landscape

4.1 Overview

4.2 Europe PEST Analysis

4.3 Experts Opinion

5. Europe Plant-based Vaccines Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Significant Rise in Number of Research & Development (R&D) Activities in Plant-Based Vaccines

5.1.2 Infectious Diseases Getting Quite Prevalent

5.2 Market Restraints

5.2.1 Manufacturing Plant-Based Vaccines Facing Potential Risk of Contamination Including Environmental Risks

5.3 Market Opportunities

5.3.1 Production Surge in Plant-Based Vaccines

5.4 Future Trends

5.4.1 High Rise in Product Approvals

5.5 Impact Analysis

6. Plant-based Vaccines Market– Europe Analysis

6.1 Europe Plant-based Vaccines Market Revenue Forecast and Analysis

7. Europe Plant-Based Vaccines Market Analysis – By Vaccine Type

7.1 Overview

7.2 Europe Plant-based Vaccines Market Revenue Share, by Vaccine Type (2021 and 2028)

7.3 Bacterial Vaccines

7.3.1 Overview

7.3.2 Bacterial Vaccines: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)

7.4 Viral Vaccines

7.4.1 Overview

7.4.2 Viral Vaccines: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)

7.5 Parasite Vaccines

7.5.1 Overview

7.5.2 Parasite Vaccines: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)

7.6 Plant-derived Virus-like Particles (VLPs)

7.6.1 Overview

7.6.2 Plant-derived Virus-like particles (VLPs): Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)

7.7 Others

7.7.1 Overview

7.7.2 Others: Plant-based Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

8. Europe Plant-based Vaccines Market Analysis – By Source

8.1 Overview

8.2 Europe Plant-based Vaccines Market Revenue Share, by Source (2021 and 2028)

8.3 Tobacco Plant

8.3.1 Overview

8.3.2 Tobacco Plant: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)

8.4 Maize

8.4.1 Overview

8.4.2 Maize: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)

8.5 Potato

8.5.1 Overview

8.5.2 Potato: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)

8.6 Others

8.6.1 Overview

8.6.2 Others: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)

9. Europe Plant-based Vaccines Market Analysis– by Application

9.1 Overview

9.2 Europe Plant-based Vaccines Market Revenue Share, by Application (2021 and 2028)

9.3 Influenza

9.3.1 Overview

9.3.2 Influenza: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)

9.4 Zika Virus

9.4.1 Overview

9.4.2 Zika Virus: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)

9.5 Ebola Virus

9.5.1 Overview

9.5.2 Ebola Virus: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)

9.6 Poultry Disease

9.6.1 Overview

9.6.2 Poultry Disease: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)

9.7 Covid-19

9.7.1 Overview

9.7.2 COVID-19: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)

9.8 Others

9.8.1 Overview

9.8.2 Others: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)

10. Europe Plant-based Vaccines Market – Country Analysis

10.1 Overview

10.1.1 Europe: Plant-based Vaccines Market, by Country, 2021 & 2028 (%)

10.1.1.1 Germany: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.1.1 Germany: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.1.2 Germany: Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)

10.1.1.1.3 Germany: Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)

10.1.1.1.4 Germany: Plant-based Vaccines Market, By Application– Revenue and Forecast to 2028 (USD Million)

10.1.1.2 France: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.2.1 France: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.2.2 France: Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)

10.1.1.2.3 France: Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)

10.1.1.2.4 France: Plant-based Vaccines Market, By Application– Revenue and Forecast to 2028 (USD Million)

10.1.1.3 UK: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.3.1 UK: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.3.2 UK: Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)

10.1.1.3.3 UK: Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)

10.1.1.3.4 UK: Plant-based Vaccines Market, By Application– Revenue and Forecast to 2028 (USD Million)

10.1.1.4 Italy: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.4.1 Italy: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.4.2 Italy: Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)

10.1.1.4.3 Italy: Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)

10.1.1.4.4 Italy: Plant-based Vaccines Market, By Application– Revenue and Forecast to 2028 (USD Million)

10.1.1.5 Spain: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.5.1 Spain: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.5.2 Spain: Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)

10.1.1.5.3 Spain: Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)

10.1.1.5.4 Spain: Plant-based Vaccines Market, By Application– Revenue and Forecast to 2028 (USD Million)

10.1.1.6 Rest of Europe: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.6.1 Rest of Europe: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.6.2 Rest of Europe: Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)

10.1.1.6.3 Rest of Europe: Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)

10.1.1.6.4 Rest of Europe: Plant-based Vaccines Market, By Application– Revenue and Forecast to 2028 (USD Million)

11. Impact Of COVID-19 Pandemic On Europe Plant-based Vaccines Market

11.1 Europe: Impact Assessment of COVID-19 Pandemic

12. Plant-based Vaccines Market –Industry Landscape

12.1 Overview

12.2 Growth Strategies in the Plant-based Vaccines Market, 2019-2021

12.3 Organic Developments

12.3.1 Overview

12.4 Inorganic Developments

12.4.1 Overview

13. Company Profiles

13.1 British American Tobacco p.l.c.

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 ICON GENETICS GMBH

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 CREATIVE BIOLABS, INC.

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 LENIOBIO

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 LEAF EXPRESSION SYSTEMS LTD.

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 ZYUS LIFE SCIENCES INC.

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. Germany: Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)

Table 2. Germany: Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)

Table 3. Germany: Plant-based Vaccines Market, By Application – Revenue and Forecast to 2028 (USD Million).

Table 4. France: Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)

Table 5. France: Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)

Table 6. France: Plant-based Vaccines Market, By Application – Revenue and Forecast to 2028 (USD Million).

Table 7. UK: Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)

Table 8. UK: Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)

Table 9. UK: Plant-based Vaccines Market, By Application – Revenue and Forecast to 2028 (USD Million).

Table 10. Italy: Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)

Table 11. Italy: Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)

Table 12. Italy: Plant-based Vaccines Market, By Application – Revenue and Forecast to 2028 (USD Million).

Table 13. Spain: Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)

Table 14. Spain: Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)

Table 15. Spain: Plant-based Vaccines Market, By Application – Revenue and Forecast to 2028 (USD Million).

Table 16. Rest of Europe: Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)

Table 17. Rest of Europe: Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)

Table 18. Rest of Europe: Plant-based Vaccines Market, By Application – Revenue and Forecast to 2028 (USD Million).

Table 19. Recent organic developments in the Plant-based Vaccines Market

Table 20. Glossary of Terms, Europe Plant-based vaccines devices market

LIST OF FIGURES

Figure 1. Europe Plant-based Vaccines Market Segmentation

Figure 2. Europe Plant-based Vaccines Market Segmentation, By Country

Figure 3. Europe Plant-based Vaccines Market Overview

Figure 4. Bacterial Vaccines Held the Largest Share of the Vaccine Type Segment in Europe Plant-based Vaccines Market

Figure 5. Germany to Show Significant Growth during Forecast Period

Figure 6. Europe PEST Analysis

Figure 7. Europe Plant-Based Vaccines Market Impact Analysis of Driver and Restraints

Figure 8. Europe Plant-based Vaccines Market– Revenue Forecast and Analysis – 2019- 2028

Figure 9. Europe Plant-based Vaccines Market Revenue Share, by Vaccine Type (2021 and 2028)

Figure 10. Europe Bacterial Vaccines: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)

Figure 11. Europe Viral Vaccines: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)

Figure 12. Europe Parasite Vaccines: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)

Figure 13. Europe Plant-derived Virus-like particles (VLPs): Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)

Figure 14. Europe Others: Plant-based Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15. Europe Plant-based Vaccines Market Revenue Share, by Source (2021 and 2028)

Figure 16. Europe Tobacco Plant: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)

Figure 17. Europe Maize: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)

Figure 18. Europe Potato: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)

Figure 19. Europe Others: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)

Figure 20. Europe Plant-based Vaccines Market Revenue Share, by Application (2021 and 2028)

Figure 21. Europe Influenza: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)

Figure 22. Europe Zika Virus: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)

Figure 23. Europe Ebola Virus: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)

Figure 24. Europe Poultry Disease: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)

Figure 25. Europe COVID-19: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)

Figure 26. Europe Others: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)

Figure 27. Europe: Plant-based Vaccines Market, by Key Country – Revenue (2021) (USD Million)

Figure 28. Europe: Plant-based Vaccines Market, by Country, 2021 & 2028 (%)

Figure 29. Germany: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)

Figure 30. France: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)

Figure 31. UK: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)

Figure 32. Italy: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)

Figure 33. Spain: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)

Figure 34. Rest of Europe: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)

Figure 35. Impact of COVID-19 Pandemic In European Country Markets

Figure 36. Growth Strategies in the Plant-based Vaccines Market, 2019-2021

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe plant-based vaccines market
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Europe plant-based vaccines market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the plant-based vaccines market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
Europe Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software and Serv..	May 2022
Europe Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Electric P..	May 2022
Europe In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe Mixing Configurat..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000

$3000

GET FREE SAMPLE PDF

Inquire before Buying Inquire for Discount

Subscription Member Price: FREE

Get Subscription

TABLE OF CONTENTS

1. Introduction

2. Europe Plant-based Vaccines Market – Key Takeaways

3. Research Methodology

4. Europe Plant-based Vaccines Market– Market Landscape

5. Europe Plant-based Vaccines Market – Key Market Dynamics

6. Plant-based Vaccines Market– Europe Analysis

7. Europe Plant-Based Vaccines Market Analysis – By Vaccine Type

8. Europe Plant-based Vaccines Market Analysis – By Source

9. Europe Plant-based Vaccines Market Analysis– by Application

10. Europe Plant-based Vaccines Market – Country Analysis

11. Impact Of COVID-19 Pandemic On Europe Plant-based Vaccines Market

12. Plant-based Vaccines Market –Industry Landscape

13. Company Profiles

14. Appendix

LIST OF TABLES

LIST OF FIGURES

Request for Free Sample

TABLE OF CONTENTS

1. Introduction

2. Europe Plant-based Vaccines Market – Key Takeaways

3. Research Methodology

4. Europe Plant-based Vaccines Market– Market Landscape

5. Europe Plant-based Vaccines Market – Key Market Dynamics

6. Plant-based Vaccines Market– Europe Analysis

7. Europe Plant-Based Vaccines Market Analysis – By Vaccine Type

8. Europe Plant-based Vaccines Market Analysis – By Source

9. Europe Plant-based Vaccines Market Analysis– by Application

10. Europe Plant-based Vaccines Market – Country Analysis

11. Impact Of COVID-19 Pandemic On Europe Plant-based Vaccines Market

12. Plant-based Vaccines Market –Industry Landscape

13. Company Profiles

14. Appendix

LIST OF TABLES

LIST OF FIGURES

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

Request for Free Sample